Eterna Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | 2.01 | -100% |
| P/S |
|
146.14 | 33.44 | 337.07% |
|
|
| P/BV |
|
4.45 | 4.64 | -4.16% |
|
|
| P/FCF |
|
0 | 42.53 | -100% |
|
|
| Ev/Ebitda |
|
-2.26 | -17.68 | -87.21% |
|
|
| Ev/S |
|
650.08 | 22.59 | 2777.15% |
|
|
| Ev/FCF |
|
-2.16 | 47.55 | -104.55% |
|
|
| E/P |
|
0 | 0.0182 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-28751.47 | -14.2 | 202321.76% | -24666774.02 | -99.88% |
| ROE |
|
-970.35 | 9.78 | -10019.08% |
|
|
| ROA |
|
-44.1 | 0.33 | -13462.15% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-31864.71 | -26.41 | 120536.48% |
|
|
| ROCE |
|
-925.84 | 14.55 | -6463.62% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.4598 | -3.87 | -88.13% | -0.6207 | -25.93% |
| Nеt Debt/Ebitda |
|
-1.75 | -4.24 | -58.67% |
|
|
| Debt/Ratio |
|
0.183 | 0.1853 | -1.26% |
|
|
| Debt/Equity |
|
0 | 1.61 | -100% |
|
|
| Debt/Net Income |
|
-0.4149 | 10.06 | -104.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0.1344 | 43.64 | -99.69% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-99.68 | 30.62 | -425.54% | ||
| Growth impulse Ebitda in 5 years |
|
-483.35 | -17.42 | 2674.68% | ||
| Growth impulse Net Income in 5 years |
|
983.4 | -52.26 | -1981.75% | ||
| Growth impulse FCF in 5 years |
|
-885.65 | -31.68 | 2695.61% | ||
| Growth impulse EPS in 5 years |
|
472.69 | -61.82 | -864.62% |
IP Score
3.45/10
